Image For Activity Cover
Evidence-based cardiovascular therapies for patients with diabetes or metabolic syndrome
Description

Type II diabetes is not just an elevated blood glucose that causes microvascular complications, but is also a major risk factor for cardiovascular complications, including sleep apnea, hypertension, atherosclerotic diseases, and several others.

 

This session discusses the various approaches to treating patients with diabetes, including a discussion of guidelines from the American Heart Association, American College of Cardiology, American Diabetes Association and the American Association of Clinical Endocrinologists.

Learning Objectives

At the completion of this online course, the learner will be able to:

  1. Translate emerging clinical science to clinical practice in patients with cardiovascular disease and stroke.
  2. Evaluate and implement new diagnostic and therapeutic strategies for treating cardiovascular disorders and stroke.
  3. Demonstrate an understanding of newly developed concepts in the care of patients with common cardiovascular problems including atrial fibrillation, hypertension, heart failure, and dyslipidemia.
  4. Describe treatment strategies for cardiovascular problems that can be deployed in the outpatient setting and keep patients out of the hospital.
  5. Describe treatment strategies for cardiovascular problems in the setting of common comorbidities.
  6. Describe the relative merits of new therapies for cardiovascular problems with respect to efficacy and cost.
Target Audience

Physicians - All CV Specialties                 

Nurses - All CV Specialties

EMS - All CV Specialties

Pharmacists - - All CV Specialties

Course Agenda
Topics Objectives
Relation Between Diabetes and Cardiovascular Events 1,3
Therapies for Individuals with Type 2 Diabetes and ASCVD Risk 1,2,4,5,6
Diabetes and Hypertension 1,2,3,5
Cardiovascular Safety Studies involving DPP-4 Inhibitors 1,3,5
Interventions that Reduce CV Death in Patients with T2DM 1,2,3,5
Comprehensive Management of Risk Factors in Patients with T2 Diabetes 1,2,3,4,5

Estimated Time: 44 Minutes
Accreditation Statement

ORIGINAL RELEASE DATE:  03/14/2018

TERMINATION DATE:  03/14/2021

LAST REVIEW DATE: March 2018

JOINT ACCREDITATION TERM: 03/14/201803/14/2021


In support of improving patient care, this activity has been planned and implemented by the American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

AMA Credit Designation Statement - Physicians

The American Heart Association designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

AAPA Credit Acceptance Statement – Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.75 hours of Category 1 credit for completing this program.

 

AANP Credit Acceptance Statement – Nurse Practitioners

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

 

ANCC Credit Designation Statement - Nurses

The maximum number of hours awarded for this CE activity is 0.75 contact hours.

 

ACPE Credit Designation Statement – Pharmacists

ACPE Credit: 0.75 Contact Hours.  Universal Program Number: JA0000134-0000-18-020-H04-P

Continuing Education Accreditation – Emergency Medical Services

This continuing education activity is approved by the American Heart Association, an organization accredited by the Commission on Accreditation of Pre-Hospital Continuing Education (CAPCE), for 0.75 Advanced CEHs, activity number 18-AMHA-F3-0022.

 

By claiming CAPCE credit, the claimant acknowledges the following: I understand that the American Heart Association as a requirement of CAPCE accreditation will submit a record of my course completions to the CAPCE AMS. I further understand that my course completion records may be accessed by or shared with such regulators as state EMS offices, training officers, and NREMT on a

password-protected, need-to-know basis. In addition, I understand that I may review my record of CAPCE-accredited course completions by contacting CAPCE.



Commercial Support

This activity is supported by independent medical educational grants from Pfizer, Merck, Chiesi, Amarin, Amgen, and Aegerion.

Summary
Availability: Retired
Cost: $10.00
Credit Offered:
No Credit Offered
 
 
             Submit a Support Ticket
             Write Us a Friendly Review